http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101128436-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6859 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-60 |
filingDate | 2008-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2012-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2012-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101128436-B1 |
titleOfInvention | Liver cancer prevention and treatment composition comprising star star polysaccharide extract as an active ingredient |
abstract | The present invention relates to a composition for the prevention and treatment of liver cancer comprising the starfish polysaccharide extract as an active ingredient, the polysaccharide extract not only inhibits CYP1A1 enzyme activity induced by β-NF, but also inhibits CYP2B1 enzyme activity induced by Phenobarbital. Therefore, hepatic cancer prevention effect and antimutagenic effect, and the concentration-dependent inhibition rate to the cytotoxic P450 2E1 involved in carcinogen metabolism was shown to be excellent liver cancer prevention effect.n n n n Starfish, Polysaccharide Extract, Liver Cancer, β-NF, CYP1A1, CYP2B1, Cytochrome P450 2E1, inhibition, liver cancer |
priorityDate | 2008-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 303.